CA2257234A1 - Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques - Google Patents

Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques

Info

Publication number: CA2257234A1
Authority: CA; Canada
Prior art keywords: disease; diseases; receptor; treatment; neurological disorders
Prior art date: 1996-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002257234A

Other languages

English (en)

Other versions

CA2257234C (fr

Inventor

Alan L. Mueller

Scott T. Moe

Manuel F. Balandrin

Bradford C. Vanwagenen

Eric G. Delmar

Linda D. Artman

Robert M. Barmore

Daryl L. Smith

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Shire NPS Pharmaceuticals Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-07

Filing date

1996-12-11

Publication date

1997-12-11

1996-12-11 Application filed by Individual filed Critical Individual

1996-12-11 Priority to CA002560002A priority Critical patent/CA2560002A1/fr

1996-12-11 Priority claimed from PCT/US1996/020697 external-priority patent/WO1997046511A1/fr

1997-12-11 Publication of CA2257234A1 publication Critical patent/CA2257234A1/fr

2007-01-16 Application granted granted Critical

2007-01-16 Publication of CA2257234C publication Critical patent/CA2257234C/fr

2016-12-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

208000012902 Nervous system disease Diseases 0.000 title abstract 4
208000025966 Neurological disease Diseases 0.000 title abstract 3
108090000312 Calcium Channels Proteins 0.000 title 1
102000003922 Calcium Channels Human genes 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
206010021143 Hypoxia Diseases 0.000 abstract 2
206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 2
230000007954 hypoxia Effects 0.000 abstract 2
208000028867 ischemia Diseases 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
206010019196 Head injury Diseases 0.000 abstract 1
208000023105 Huntington disease Diseases 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
208000036982 Spinal cord ischaemia Diseases 0.000 abstract 1
208000006011 Stroke Diseases 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
238000007675 cardiac surgery Methods 0.000 abstract 1
230000002612 cardiopulmonary effect Effects 0.000 abstract 1
230000005779 cell damage Effects 0.000 abstract 1
208000037887 cell injury Diseases 0.000 abstract 1
230000007278 cognition impairment Effects 0.000 abstract 1
206010015037 epilepsy Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
210000002569 neuron Anatomy 0.000 abstract 1
208000020431 spinal cord injury Diseases 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA002257234A 1996-06-07 1996-12-11 Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques Expired - Fee Related CA2257234C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002560002A CA2560002A1 (fr)	1996-06-07	1996-12-11	Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US66301396A	1996-06-07	1996-06-07
US08/663,013		1996-06-07
WOPCT/US96/19525		1996-12-06
US9619525		1996-12-06
PCT/US1996/020697 WO1997046511A1 (fr)	1996-06-07	1996-12-11	Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002560002A Division CA2560002A1 (fr)	1996-06-07	1996-12-11	Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques

Publications (2)

Publication Number	Publication Date
CA2257234A1 true CA2257234A1 (fr)	1997-12-11
CA2257234C CA2257234C (fr)	2007-01-16

Family

ID=26791398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002257234A Expired - Fee Related CA2257234C (fr)	1996-06-07	1996-12-11	Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques

Country Status (1)

Country	Link
CA (1)	CA2257234C (fr)

1996
- 1996-12-11 CA CA002257234A patent/CA2257234C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2257234C (fr)	2007-01-16

Similar Documents

Publication	Publication Date	Title
HK1008980A1 (en)	1999-05-21	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
EP1123922A3 (fr)	2004-01-02	Composes agissant au niveau d'un nouveau site sur des canaux calciques actives par des recepteurs, et utilises dans le traitement de troubles et de maladies neurologiques
IL118836A0 (en)	1996-10-31	Pharmaceutical compositions comprising S-(-)N-propargyl-1-aminoindan
DE60110557D1 (de)	2005-06-09	Aminoadamantan-derivate als therapeutische mittel
CA2339273A1 (fr)	2000-03-23	Acides pyrrolidine-3-carboxyliques d'alkyle ramifie
HUP9901629A2 (hu)	2000-02-28	R(+)-N-Propargil-1-amino-indán és sói, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
PL313970A1 (en)	1996-08-05	Therapeutic agents
WO2001010427A3 (fr)	2001-09-20	Utilisation topique d'agents anti-muscarinique
CA2257234A1 (fr)	1997-12-11	Composes agissant sur un nouveau site des canaux a calcium actives par recepteur et utiles pour traiter des troubles et des maladies neurologiques
MX9709911A (es)	1998-03-31	Compuestos activos en un sitio novedoso en canales de calcio operados por receptor utiles para el tratamiento de trastornos neurologicos.
MY121206A (en)	2006-01-28	Aminobenzamide compounds for the treatment of neurodegenerative disorders
AU4030495A (en)	1996-06-20	NK-1 receptor antagonists for the treatment of neuronal injury and stroke
EP0999204A4 (fr)	2001-10-04	Nouveau compose capable de promouvoir une differenciation neuronale
EP0934934A3 (fr)	1999-10-13	Procédés de préparation de 3-phenyle et 3-pyridyle-4(3H)-quinazolinones substitués et leur atropisomeres
JO1833B1 (en)	1995-07-05	Therapeutic agents
RU95121818A (ru)	1997-06-10	Новые триазолопирамидоны, их получение и применение

Legal Events

Date	Code	Title	Description
2001-12-06	EEER	Examination request
2009-12-11	MKLA	Lapsed